Trial Profile
N8: Dose-Intensive Chemotherapy Plus Biologics in the Treatment of Neuroblastoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Monoclonal antibody 3F8 (Primary) ; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Isotretinoin; Thiotepa; Topotecan; Vincristine
- Indications Neuroblastoma
- Focus Therapeutic Use
- 22 Dec 2009 Actual end date (JAn 2007) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2005 New trial record.